Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

List of DDDs for 3 years revision

The DDDs, which will be reviewed at the March 2020 meeting (3 year revision) are listed below. See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2020.

ATC code	ATC level name (INN/generic name)	DDD	Unit	Adm.route

A02BX14	rebamipide	0.3	g	O
A05AA04	obeticholic acid	10	mg	O
A06AX07	plecanatide	3	mg	O
A10BF03	voglibose	0.6	mg	O
A10BH07	evogliptin	5	mg	O
A16AX14	migalastat	61.5	mg	O
B01AC26	vorapaxar	2.08	mg	O
B01AC27	selexipag	1.8	mg	O
B03AB09	ferric proteinsuccinylate	80	mg	O Fe3+
C09CA10	fimasartan	60	mg	O
H05BX04	etelcalcetide	2.1	mg	P
J01DD52	ceftazidime and beta-lactamase inhibitor	6	g	P
J05AF13	tenofovir alafenamide	25	mg	O
L03AA17	pegteograstim	0.3	mg	P
L04AC13	ixekizumab	2.9	mg	P
L04AX03	methotrexate	2.5	mg	P
N04BX04	opicapone	50	mg	O
N05AX16	brexpiprazole	3	mg	O
N07BC05	levomethadone	15	mg	O
N07XX11	pitolisant	18	mg	O
R06AA09	doxylamine	25	mg	O
R06AE03	cyclizine	0.1	g	P

Last updated: 2019-12-12